Judge approves Bayer's $7.25 billion Roundup cancer settlement
A St. Louis judge on Friday approved Bayer's settlement of up to $7.25 billion, paid over as long as 21 years, for current and future U.S. claims that Roundup causes non-Hodgkin lymphoma. Average payouts range from about $10,000 to $165,000. Bayer denies that Roundup causes cancer.
AI-assisted · US Brief desk · Sources listed below
What happened
St. Louis Circuit Judge Timothy Boyer on Friday approved Bayer's settlement of up to $7.25 billion to resolve claims from U.S. cancer patients who say the company should have warned that its Roundup weedkiller could cause non-Hodgkin lymphoma, the AP reported. Boyer called the deal "fair, reasonable, and adequate," the BBC reported, and rejected all objections, according to Law.com.
Why it matters
The deal gives Bayer some financial certainty after litigation costs led it to consider pulling Roundup from U.S. farm markets, the AP reported. The German company inherited the lawsuits when it bought Monsanto in 2018 and has already removed glyphosate from new Roundup versions sold for home lawns and gardens.
What’s next
Bayer will make annual payments into the settlement fund for up to 21 years. The deal also covers people exposed before it was proposed in February who are diagnosed later, the AP said. The approval order can still be appealed, and Bayer said any appeal would pause further payments until it is resolved; no appeal had been reported as of Sunday morning.
More context
Who gets paid: The nationwide settlement covers Roundup users who are already sick and those diagnosed in future years, the AP said. Bayer will pay into a fund every year for up to 21 years. Average payouts range from about $10,000 to $165,000. Farm, industrial or turf workers with long exposure who were diagnosed with an aggressive form before age 60 could average $165,000; people diagnosed at 78 or older would average about $10,000. The deal includes $600 million for attorneys' fees.
The judge's reasoning: Boyer wrote that the total is "among the largest in the history of mass tort personal-injury class action settlements." He said there was a risk Bayer would have filed for bankruptcy protection if he had rejected it, the AP reported.
Both sides of the deal: Bayer CEO Bill Anderson said the court-approved settlement is "a decisive milestone in the company's strategy to mitigate the risks of both pending and future Roundup litigation." Christopher Seeger, a court-appointed lawyer for cancer patients, said it "delivers guaranteed compensation to Roundup cancer victims who have waited more than a decade for justice." Attorney Gerson Smoger argued at a September hearing that it locks in future claimants for decades with no chance at punitive damages, the AP reported.
The science dispute: Bayer denies that Roundup causes cancer. The World Health Organization's cancer research agency classified its active ingredient, glyphosate, as "probably carcinogenic" in 2015. The U.S. Environmental Protection Agency has found it is not likely to cause cancer in humans when used as directed, the AP noted.
By the numbers: About 200,000 Roundup claims have been made against Bayer, the AP said. Only a couple dozen cases have reached juries, with mixed results. A Georgia jury once awarded plaintiffs $2.1 billion, while a Missouri jury sided with Bayer in October. Bayer had already set aside $16 billion for Roundup legal costs before this deal. In June, the Supreme Court ruled 7-2 that Bayer cannot be sued in state courts for failing to warn about cancer, because federal rules do not require that label, the BBC reported.
6 listed sources
- AP via WSB-TV (David A. Lieb), Court approves $7.25 billion settlement with Bayer over claims Roundup weed killer caused cancer, Nov. 20, 2026
- AP, Court approves $7.25 billion settlement with Bayer for Roundup cancer claims, Nov. 20, 2026
- BBC News (Madeline Halpert), Judge approves $7.25bn settlement for Roundup weedkiller cancer claims, Nov. 20, 2026
- Law.com, Missouri Judge Grants Final Approval to $7.25B Class Action Settlement Over Roundup, Nov. 20, 2026
- Bloomberg Law, Bayer's $7.25 Billion Roundup Settlement Approved by Judge, Nov. 20, 2026
- Bayer (press release), Court grants final approval to Roundup class settlement, Nov. 20, 2026
References listed by US Brief; a source count is not a verification score.
Editorial sourcing notes
The hero photo shows downtown St. Louis, including the Civil Courts Building, which houses the St. Louis Circuit Court (file photo, 2023). The body photo shows a field in Germany, not a U.S. claimant's farm.
Like US Brief? You can support it with a tip.